Safety of rasagiline in elderly patients with Parkinson disease

Neurology

Volumn 66, Issue 9, 2006, Pages 1427-1429

  Goetz, C G ^a   Schwid, S R ^b   Eberly, S W ^b   Oakes, D ^b   Shoulson, I ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; MONOAMINE OXIDASE INHIBITOR; PLACEBO; RASAGILINE;

AGED; AGING; ARTICLE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DYSKINESIA; GERIATRIC PATIENT; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; CONFUSION; DISORDERS OF EXCESSIVE SOMNOLENCE; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; FEMALE; HALLUCINATIONS; HUMANS; HYPOTENSION, ORTHOSTATIC; INCIDENCE; INDANS; LEVODOPA; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIALS;

EID: 33646676086     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000210692.95595.1c     Document Type: Article

References (8)

1. Parkinson Study Group. A controlled trial of rasagiline in early Parkinson's disease (the TEMPO study). Arch Neurol 2002;59:1937-1943.
2. Parkinson Study Group. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson's disease and motor fluctuations: the PRESTO study. Arch Neurol 2005;62:241-248.
3. Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of PD (2001): treatment guidelines. Neurology 2001;56(suppl 1):S1-S88.
4. Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996;46:1470.
5. Bartlett MS. Contingency table interactions. J R Stat Soc 2(suppl 2):248-252.
6. Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson's disease. Arch Neurol 1996;53:1265-1268.
7. Shulman LM, Minagar A, Rabinstein A, Weiner WJ. The use of dopamine agonists in very elderly patients with PD. Mov Disord 2000;15:664-668.
8. Korczyn AD, Keens J, Oldham M, Macrae S. The safety and efficacy of ropinirole as early therapy in elderly patients with PD. Neurology 2000;54 (suppl 3):A90.